{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T05:41:58Z","timestamp":1669182118452},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW - Fortschritte der Medizin"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s15006-022-1903-y","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T12:21:30Z","timestamp":1669119690000},"page":"54-61","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Parasiten im Gep\u00e4ck"],"prefix":"10.1007","volume":"164","author":[{"given":"Astrid","family":"Niederfahrenhorst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"1903_CR4604","doi-asserted-by":"crossref","unstructured":"Peters TE, Kreuels B, Addo MM et al. Risk factors for and management of metronidazole-refractory giardiasis in international travellers: A retrospective analysis. Travel Med Infect Dis 2021; 43: 102090","DOI":"10.1016\/j.tmaid.2021.102090"},{"key":"1903_CR4608","doi-asserted-by":"crossref","unstructured":"Canete R, Noda AL, Rodriguez M et al. 5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study. Clin Microbiol Infect 2020; 26: 1092.e1-1092.e6","DOI":"10.1016\/j.cmi.2019.12.017"},{"key":"1903_CR4612","doi-asserted-by":"crossref","unstructured":"Neumayr A, Schunk M, Theunissen C et al. Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study. Clin Infect Dis 2021; 73: 1517-1523","DOI":"10.1093\/cid\/ciab513"},{"key":"1903_CR4616","doi-asserted-by":"crossref","unstructured":"Lucas Dato A, Pacheco-Tenza MI, Borrajo Brunete E et al. Strongyloidiasis in Southern Alicante (Spain): Comparative Retrospective Study of Autochthonous and Imported Cases. Pathogens 2020; 9: 601","DOI":"10.3390\/pathogens9080601"},{"key":"1903_CR4620","doi-asserted-by":"crossref","unstructured":"Ross SA, Pintilie H, Hatcher J et al. Strongyloides stercoralis infection in HIV-positive men who have sex with men. Int J STD AIDS 2020; 31: 398-401","DOI":"10.1177\/0956462420910048"},{"key":"1903_CR4624","doi-asserted-by":"crossref","unstructured":"Krolewiecki A, Nutman TB. Strongyloidiasis: A Neglected Tropical Disease. Infect Dis Clin North Am 2019; 33: 135-151","DOI":"10.1016\/j.idc.2018.10.006"},{"key":"1903_CR4628","doi-asserted-by":"crossref","unstructured":"Salvador F, Lucas-Dato A, Roure S et al. Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol. Pathogens 2021; 10: 812","DOI":"10.3390\/pathogens10070812"},{"key":"1903_CR4632","doi-asserted-by":"crossref","unstructured":"Colley DG, Bustinduy AL, Secor WE et al. Human schistosomiasis. Lancet 2014; 383: 2253-2264","DOI":"10.1016\/S0140-6736(13)61949-2"},{"key":"1903_CR4636","doi-asserted-by":"crossref","unstructured":"Rothe C, Zimmer T, Schunk M et al. Developing Endemicity of Schistosomiasis, Corsica, France. Emerg Infect Dis 2021; 27: 319-321","DOI":"10.3201\/eid2701.204391"},{"key":"1903_CR4640","doi-asserted-by":"crossref","unstructured":"Richter J, Bode JG, Blondin D et al. Severe liver fibrosis caused by Schistosoma mansoni: management and treatment with a transjugular intrahepatic portosystemic shunt. Lancet Infect Dis 2015; 15: 731-737","DOI":"10.1016\/S1473-3099(15)70009-5"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-022-1903-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15006-022-1903-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-022-1903-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T12:27:39Z","timestamp":1669120059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-022-1903-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":10,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1903"],"URL":"https:\/\/doi.org\/10.1007\/s15006-022-1903-y","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"value":"1438-3276","type":"print"},{"value":"1613-3560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"18 November 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Die Autorinnen erkl\u00e4ren, dass sie sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten lie\u00dfen. Sie legen folgende potenzielle Interessenkonflikte offen: keine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Der Verlag erkl\u00e4rt, dass die inhaltliche Qualit\u00e4t des Beitrags durch zwei unabh\u00e4ngige Gutachten best\u00e4tigt wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere f\u00fcr Pr\u00e4parate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}